Top Markets
#1 CoW Protocol CoW Protocol +84.93%
#2 EXOD EXOD +56.80%
#3 Glidr Glidr +38.25%
#4 Walrus Walrus +36.32%
#5 Humanity Humanity +16.84%
#6 Velvet Velvet +16.00%
#7 Cysic Cysic +15.83%
#8 The Black Bull The Black Bull +14.62%
#9 Tutorial Tutorial +14.59%
#10 Plume Plume +14.14%
Coin of the day
CoW Protocol CoW Protocol
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
ASLAN Pharmaceuticals Limited ASLAN Pharmaceuticals Limited

ASLAN Pharmaceuticals Limited

ASLN
Rang in Aktien #37031
ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the... ASLAN Pharmaceuticals Limited is a biopharmaceutical firm operating at the clinical stage, primarily focused on immunology, and dedicated to creating innovative treatments that profoundly enhance patients' lives. Its advanced therapeutic pipeline features ASLAN004, a monoclonal antibody currently being evaluated for atopic dermatitis and a range of other immunological disorders. Also under development is ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase, intended to treat autoimmune conditions. The company is involved in a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd., aimed at pioneering immuno-oncology therapeutics that target the AhR pathway. Furthermore, ASLAN maintains partnerships with various entities, including Almirall, Array BioPharma, and CSL Limited. Established in 2010, the company's headquarters are located in Singapore.
Aktienkurs
$0.6
Zuletzt synchronisiert: 2024-08-14
Marktkapitalisierung
$2.09M
Veränderung (1 Tag)
0.00%
Veränderung (1 Jahr)
0.00%
Land
SG
Handel ASLAN Pharmaceuticals Limited (ASLN)

Kategorie

Healthcare
Anzahl der ausstehenden Aktien von ASLAN Pharmaceuticals Limited (ASLN)
Anzahl der ausstehenden Aktien zum March 2024: 4.67M
Laut den neuesten Finanzberichten und dem Aktienkurs von ASLAN Pharmaceuticals Limited beträgt die aktuelle Anzahl der ausstehenden Aktien 4.67M. Am Ende von December 2022 hatte das Unternehmen 3.49M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von ASLAN Pharmaceuticals Limited (ASLN) von 2014 bis 2026
Ausstehende Aktien am Ende jedes Jahres
Jahr Ausstehende Aktien ändert
2026 (TTM) 4.67M 13.50%
2023 4.11M 17.93%
2022 3.49M 7.07%
2021 3.26M 69.43%
2020 1.92M 18.37%
2019 1.62M 8.45%
2018 1.50M 20.35%
2017 1.24M -4.34%
2016 1.30M 136.41%
2015 550.22K 761.10%
2014 63.90K 0.00%
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
Unternehmen Ausstehende Aktien Unterschied Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 5,339.61%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 62.19M 1,232.28%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 0.00 -100.00%
BE